Download Manchester Cancer

Manchester Cancer
Manchester Cancer is an Integrated Cancer System for Greater Manchester and Cheshire. It
brings together service delivery with the two other key components of cancer treatment;
research and education. Its aim is to make the city region of Manchester one of the top five
Integrated Cancer Systems in the world, securing world class outcomes for the cancer
patients and populations served, so that by 2020 more than two thirds of newly diagnosed
patients will survive their cancer for more than 5 years.
Manchester Cancer is made up of three strands; Manchester Cancer Research, Manchester
Cancer Education and Greater Manchester Cancer Services. Greater Manchester Cancer
Services (GMCS), and its respective Provider Board, is the strand that covers the operational
delivery of cancer services.
GMCS represents the arrangements put in place in order to deliver the commitment made
at the Greater Manchester Cancer Summit (September 2012) to create the whole system
change necessary to achieve world‐class cancer outcomes. It specifically addresses the
agreement to develop a new unified provider board, which will be responsible for providing
single integrated pathways of care across organisational boundaries so that patients from
across Greater Manchester and Cheshire receive the same high quality service, wherever
they live.
The following provider organisations have co-created Greater Manchester Cancer Services:
•Central Manchester University Hospitals NHS Foundation Trust
•Stockport NHS Foundation Trust •Tameside Hospital NHS Foundation Trust
•Bolton NHS Foundation Trust • Pennine Acute NHS Trust
•Salford Royal NHS Foundation Trust •East Cheshire NHS Trust
•Wrightington, Wigan and Leigh NHS Foundation Trust •The Christie NHS Foundation Trust
•University Hospital of South Manchester NHS Foundation Trust
•Mid Cheshire Hospitals NHS Foundation Trust
GMCS Provider Board and its partners will work together to contribute to the objectives of
Manchester Cancer for clinical services endorsed by the Manchester Academic Health
Science Centre and the Academic Health Science Network:




Progressively increasing 1, 3 and 5 year survival especially for the common cancers so
that our overall ambition of two thirds of patients surviving for more than 5 years can
be achieved by 2020
Going beyond securing compliance with national Improving Outcomes Guidance by
achieving over 90% compliance for all MDTs against the national standards by 2014
Consistently achieving scores in the upper quartile of all domains in the National Cancer
Patient Survey by 2014
Demonstrating high standards of Patient Safety through the minimisation of defined
adverse events for cancer care

Promoting increased ease and equity of access to clinical services, research
opportunities and educational opportunities across our communities, organisations and
staff groups
It is recognised these objectives represent considerable ambition and will require focussed
collective effort if they are to be achieved. This will require the members of GMCS to work
with commissioners to develop and implement services specifications that deliver agreed
objectives for each pathway of care.
Core to effective delivery will be patient and population, strong partnership working and
governance and clear clinical leadership across traditional organisational boundaries. This
radical refocusing of our hospitals towards working in partnership around patients will
require us to work together as a co-ordinated, coherent system; providing comprehensive
pathways of excellent care for every patient irrespective of where they access our system or
the type of cancer they have.
We are seeking to appoint a Clinical Director for the GMCS Provider Board to support these
changes through dedicated personal and professional leadership, on a part- time basis in the
first instance.
A key early task of the Clinical Director role will be to oversee the configuration of specialist
cancer surgical sites across GMCS in order to comply with Improving Outcomes Guidance
and the successful post-holder will advise on the operational agenda, timescales and other
implications of implementation. In due course the GMCS Provider Board shall nominate a
lead provider and single clinical lead for each of the specialist cancer surgical sites.
Clinical Director – Greater Manchester Cancer Services
Leadership
The Clinical Director for GMCS will promote and support partnership working for patient
benefit through the example of their own personal approach and constant focus on
delivering the best possible pathway and experience for patients. They will be responsible
for the development of leadership skills and behaviours that deliver an integrated
partnership around patients and local populations.
As the most senior clinician and executive within GMCS, the Clinical Director will act as a
figurehead: representing GMCS and Manchester Cancer – and its component partners – at a
local and national level. The post-holder will need to have the experience and capability to
promote Manchester Cancer on a local, national and global stage and harness international
innovation and learning for the benefit of the whole population served by the GMCS
Provider Board and its integrated cancer system.
The Clinical Director will need to have established through their career impeccable and
demonstrable clinical credibility, as well as a reputation for integrity that secures the
confidence of clinical staff across Manchester Cancer. They may need to lead in the
consideration of challenging decisions, sometimes in the face of opposition, where these are
in the best interests of significantly improved patient outcome and experience.
The CMO will provide leadership for Cancer Pathway Directors, supporting their professional
development and empowering them to take accountability for the quality and delivery of an
entire cancer pathway across Greater Manchester and Cheshire, and beyond for the more
rare tumour sites. The role will support each cancer pathway to design an annual plan with
clear objectives and milestones based on a patient-centred, populated scorecard to improve
patient experience and outcomes of care in Manchester Cancer. It will also engage primary
care clinicians through education and development in order to achieve the system wide
improved outcomes.
Governance
The governance structure of GMCS Provider Board is still under development and will
further inform this job description, but it is acknowledged its organisational form will have a
Board of constituent partners to support and oversee the delivery of agreed objectives. The
Clinical Director will be accountable to the Independent Chair of the GMCS Provider Board
for the delivery of these objectives.
As the leader and most senior clinician within GMCS, the Clinical Director will need to be
both a committed member of the Manchester Cancer Board, provide leadership and act as
the clinical advisor to the independent Chair of the GMCS Provider Board. They will provide
a pivotal voice and guidance in designing and implementing a GMCS clinical strategy.
Communication & Involvement
The Clinical Director will encourage involvement of partners from all professional
backgrounds in the evolution of GMCS. They will exemplify Manchester Cancer’s ambition to
communicate its vision to deliver real change for local communities and to ensure
Manchester Cancer is world class.
The Clinical Director will establish effective leadership relationships across professional and
organisational boundaries, attracting expertise from external bodies and user involvement
specialists to develop the patient role in emerging GMCS projects and structures.
The post will drive information sharing and transparency of clinical decision-making and
care pathways across Manchester Cancer, promoting informed patient choice and
integrated care.
Research & Innovation
The Clinical Director will lead a programme of work to embed research across GMCS for
personalised care, equitable access to trials, the discovery of new treatments and evaluating
new ways of working together with patients.
They will guide the local clinical leads of the National Cancer Research Network and work
with the Directors of Manchester Cancer Research and Manchester Cancer Education to
develop Manchester Cancer as an efficient platform and partner for industry to bring access
to innovation for the population.
The Candidate
An outstanding clinical leader with experience gained working across organisational
boundaries in the Health Service and/or medical research sector. The candidate will have
exceptional leadership and relationship management skills, with the ability to work with a
diverse group of high profile external stakeholders.
An individual who can lead an ambitious agenda to change health outcomes at pace and
scale; who has the strength to drive change in a challenging climate. They will have a clear
personal commitment to improving health outcomes that matter to our population, and
unrelenting determination to structure care around the patient.
Person Specification
Essential Criteria








Demonstrable track record of leading positive change with excellent leadership,
influencing and communication skills.
International profile, with an impressive track record in research.
Ability to communicate complex and challenging issues to stakeholders in science and
healthcare and more widely across academia, the NHS and government.
Ability to collaborate with and influence a wide range of individuals and groups in
professionally based organisations whilst remaining sensitive to the autonomy and
individual accountability of the member and partner organisations.
Experience of formulating and delivering a strategic plan and experience of strategic
leadership of clinical or research services, especially to drive new models of care.
Relevant clinical qualifications plus a higher academic degree, e.g. MD/MS or PhD or
evidence of an equivalent level in research publications.
Understanding of the role and remit of the NHS; and awareness of relevant cancer
services and NHS policy; and the importance of clinical and research governance in
clinical service delivery.
Possessing the highest ethical and professional standards in research, education and
clinical practice and a flexible attitude.
Desirable Criteria





Active research profile with a track record of external research grant funding –
acknowledging the shift in career this post will bring to a greater focus on leadership.
Track record of leading or participating in successful applications for programme
grants from major funding agencies.
Experience of establishing new governance structures and procedures based on
networks of influence and persuasion in a clinical environment.
Involvement in continuing professional development and appreciation of Equal
Opportunities policy and its application in the workplace; experience of recruitment
and selection.
Experience of successful liaison with industry partners for the benefit of population
health
Terms and Conditions
This position will be for at least 5 PAs with an appointment period of 3 years with annual
review. The post holder will be paid on a pro rata basis for this time. The appointment will
initially be hosted by The Christie NHS Foundation Trust and will be therefore be subject to
The Christie’s terms and conditions of employment. The Director, GMCS will be
remunerated by agreement with the individual appointed and travel and other appropriate
expenses will be paid in accordance with the policies of The Christie.
Application & Selection Process
All applicants will be acknowledged.
Candidates wishing to apply should submit by email a detailed CV to include names and
contact details of three referees, a full list of publications and a covering letter or supporting
statement which addresses the criteria set out in the candidate specification. Applications
should be sent to [email protected]
Appointment to this post will be subject to the agreement of the GMCS Provider Board.